$14MSeed, 29 July 2025
Funds advance toward clinical studies early next year.
- Amount
- $14M
- Stage
- Seed
- Announced
- 29 July 2025
- Lead
- RA Capital Management
- Other investors
- AN Venture Partners, UTEC
- Use of funds
- Funds advance toward clinical studies early next year.
- Checked
- Announced by the company
- Sources
- Pahr Therapeutics raises $14M (date approx) business.mammothtimes.com
Pahr Therapeutics raises $14M (date approx) pulse2.com